Pancreatic Cancer Research

ResearcherHeinrich Heine University DüsseldorfActive in the last 2 years

Nicole Elisabeth Teusch

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9030-1493; OpenAlex author ID A5058384908, A5137602730. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
12
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 7

  1. The substance P/ Neurokinin-1 receptor signaling drives perineural invasion in pancreatic ductal adenocarcinoma (PDAC). Last author DOI 10.3389/fcell.2026.1876023↗
  2. Targeting stroma-mediated T-cell exclusion and functional exhaustion in pancreatic ductal adenocarcinoma through CXCR4 and PD-1 blockade. Last author DOI 10.3389/fimmu.2026.1844781↗
  3. Modelling of the multicellular tumor microenvironment of pancreatic ductal adenocarcinoma (PDAC) on a fit-for-purpose biochip for preclinical drug discovery. Last author DOI 10.1039/d4lc01016g↗
  4. Novel Histone Deacetylase (HDAC) Inhibitor Induces Apoptosis and Suppresses Invasion via E-Cadherin Upregulation in Pancreatic Ductal Adenocarcinoma (PDAC). Last author DOI 10.3390/ph17060752↗
  5. Indole Diketopiperazine Alkaloids from the Marine Sediment-Derived Fungus Aspergillus chevalieri against Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/md22010005↗
  6. Pseudopterosin and O-Methyltylophorinidine Suppress Cell Growth in a 3D Spheroid Co-Culture Model of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/bioengineering7020057↗
  7. A Synthetic Glycopeptide Vaccine for the Induction of a Monoclonal Antibody that Differentiates between Normal and Tumor Mammary Cells and Enables the Diagnosi… Co-author DOI 10.1002/anie.201509935↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alina Deipenbrock · 5 shared papers, 2023–2026 · strength 1.27
  2. Katja Schiedlauske · 3 shared papers, 2023–2026 · strength 0.69
  3. Dirk Weyhe · 2 shared papers, 2026 · strength 0.62
  4. Iréne Esposito · 2 shared papers, 2026 · strength 0.62
  5. Kaan Çifcibaşı · 1 shared paper, 2026 · strength 0.30
  6. İhsan Ekin Demir · 1 shared paper, 2026 · strength 0.30
  7. Dina H. El‐Kashef · 1 shared paper, 2023 · strength 0.16
  8. Bailu Xie · 1 shared paper, 2020 · strength 0.10
  9. Randall J. Mrsny · 1 shared paper, 2020 · strength 0.10
  10. Mert Erkan · 1 shared paper, 2020 · strength 0.10
  11. Björn Palitzsch · 1 shared paper, 2016 · strength 0.06
  12. Horst Kunz · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.